Healthcare
California-Based Multinational Biopharmaceutical Company
PROBLEM ENCOUNTERED
A large multinational biopharmaceutical company was unable to enter the Mexican market due to a regulation requiring a local manufacturing presence in order to sell pharmaceuticals. Further, Mexico lacked sufficient regulation for domestic production of biologic products and did not permit the import of these products.
SERVICES PROVIDED
We helped our client solve both hurdles by working with Mexican authorities, including the Ministry of Economy and COFEPRIS (FDA equivalent), to develop appropriate regulatory modifications. In tandem with providing advocacy services, we helped the company build its own in-house government relations capabilities.
OUTCOME
Our client was able to register a number of its biologic products to successfully enter the Mexican market and remains an important participant in the country’s healthcare sector, providing medications that improve the quality of life of Mexican patients and their families.
Mexican Medical Device Association
ENGAGEMENT GOAL
Mexico’s preeminent medical device association, in concert with its U.S.-based counterpart, sought to enhance awareness among key stakeholders of the industry’s contribution to Mexico’s economic development and the quality of life of its citizens. A senior-level member delegation to Mexico City provided a unique opportunity to implement a new, more active government relations strategy.
SERVICES PROVIDED
We developed an intensive schedule of high-level meetings with a range of government officials representing the ministries and agencies responsible for policies and regulation of direct relevance to the medical device industry. Our knowledge of the regulatory environment for devices and our ability to effectively reach into the Mexican administration at the highest levels, preceded by delivery of extensive written and oral briefing materials, allowed the senior leadership of the association’s member companies to advocate for policy changes and promote awareness of the industry’s role in the Mexican economy and healthcare delivery infrastructure.
OUTCOME
Our client and its members were able to deliver key messages to the appropriate policymakers and underscore the industry’s commitment to Mexico. Several of the officials with whom we met agreed to undertake follow-up actions in conjunction with our client’s local company representatives as a result of these meetings. As a result of the engagement, the medical device industry was better positioned to advance its policy advocacy objectives vis-à-vis the Peña Nieto administration.
Mexico's Leading Pharmaceutical Research Association
ENGAGEMENT GOAL
Mexico’s leading pharmaceutical research association sought to demonstrate that inadequate and inefficient healthcare spending, and the resulting limited access to innovative medicines, has a negative impact on industrial productivity and overall economic growth in Mexico.
SERVICES PROVIDED
We conducted an analysis of the impact of inadequate healthcare services on productivity in the automotive sector in the state of Guanajuato. We then worked with the association to develop effective messaging around the study’s findings and presented the results to a wide range of public- and private-sector stakeholders at a series of events in Mexico City.
OUTCOME
The report’s release received widespread coverage in the Mexican media, with its key messages frequently highlighted. The study also highlighted the potential for the automotive sector, which had been reluctant to share data, to provide additional information that could improve its accuracy and further reinforce its findings.